Joint symptoms and health-related quality of life in postmenopausal women with breast cancer who completed 5 years of anastrozole

摘要

To assess the joint symptoms and the impact on patients' health-related quality of life (HRQOL) due to 5 years of anastrozole from the baseline data in the N-SAS BC 05 trial, a randomized clinical trial was designed to assess the efficacy of 5 additional years of anastrozole among women with breast cancer.